In an effort to keep our policyholders up to date on the Berkshire Hathaway transaction, and to address questions we often get on our hotline, we have updated the information on the FAQs.
MLMIC’s Q2 financials show continued strength and stability for New York’s leading medical liability insurer. In a constantly changing insurance marketplace, it is reassuring to know that MLMIC is sound and ready to serve its policyholders.
MLMIC is pleased to announce that DFS approval of MLMIC’s 2017 rates means that base rates remain unchanged for all physician policyholders for July 1, 2017, to July 1, 2018. DFS also approved a number of specialty class changes and a small adjustment to how entity rates are calculated.
At MLMIC’s Board of Directors Meeting on May 3, Dr. Robert Menotti affirmed his retirement as President and Chairman of the Company. Subsequently, the Board elected Dr. James Reed to serve as Chairman and Dr. John Lombardo to serve as President.